Literature DB >> 12004242

Endothelial injury and dysfunction in ischemic acute renal failure.

Bruce A Molitoris1, Ruben Sandoval, Timothy A Sutton.   

Abstract

Ischemic acute renal failure is the most common cause of acute renal failure in hospitalized patients and has an average mortality rate of 50%. Although epithelial and vascular smooth muscle cell abnormalities have been clearly delineated in association with this condition, the extent of endothelial injury and dysfunction has been difficult to document, primarily for anatomic reasons. However, endothelial tight junction separation and endothelial cell detachment, blebbing, and necrosis have been observed after ischemia in other organs. In addition, adenosine triphosphate depletion studies in cultured endothelial cells have demonstrated that multiple actin-based alterations occur in a reversible and duration-dependent fashion. After an ischemic insult, total renal blood flow returns toward normal, but marked, regional alterations occur. Most affected is the outer medullary or corticomedullary junction region where blood flow remains approximately 10% of normal. In this area, the microvasculature becomes congested. Interstitial edema, red blood cell trapping, leukocyte adherence, and extravasation all contribute to this congestion. Increased expression of both P selectin and E selectin has been documented in renal endothelial cells after ischemic injury, and treatment with antibodies to either intercellular adhesion molecule-1, P selectins, or E selectins has been shown to minimize renal injury. During ischemia in vivo and adenosine triphosphate depletion in cell culture studies, F-actin destruction occurs, with polymerization leading to accumulation of intracellular actin aggregates. By using multiphoton microscopy, Voxx software, and the Tie-2 mouse with selective endothelial cell green fluorescent protein expression driven by the Tie-2 promoter, we have been able to identify macrovascular and microvascular endothelial cells in four dimensions (three dimensions plus time) intravitally. By using Texas red-labeled large molecular weight dextrans, we can document blood flow and vascular dysfunction. Intravital studies using multiphoton imaging techniques can now be conducted to identify and quantify endothelial cell injury and dysfunction in functioning organs.

Entities:  

Mesh:

Year:  2002        PMID: 12004242     DOI: 10.1097/00003246-200205001-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  36 in total

1.  Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.

Authors:  Parnell C Mattison; Angel A Soler-García; Jharna R Das; Marina Jerebtsova; Sofia Perazzo; Pingtao Tang; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

2.  Updates on Hepato-Renal Syndrome.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Anesth Clin Res       Date:  2013-09-27

3.  Semi-automated rapid quantification of brain vessel density utilizing fluorescent microscopy.

Authors:  Kaci A Bohn; Chris E Adkins; Rajendar K Mittapalli; Tori B Terrell-Hall; Afroz S Mohammad; Neal Shah; Emma L Dolan; Mohamed I Nounou; Paul R Lockman
Journal:  J Neurosci Methods       Date:  2016-06-16       Impact factor: 2.390

Review 4.  The Potential Role of Exercise-Induced Muscle Damage in Exertional Heat Stroke.

Authors:  Zidong Li; Zachary J McKenna; Matthew R Kuennen; Flávio de Castro Magalhães; Christine M Mermier; Fabiano T Amorim
Journal:  Sports Med       Date:  2021-02-02       Impact factor: 11.136

Review 5.  Strategies to optimize kidney recovery and preservation in transplantation: specific aspects in pediatric transplantation.

Authors:  Tackwa Khalifeh; Edouard Baulier; Sylvain Le Pape; Thomas Kerforne; Remy Coudroy; Souleymane Maiga; Thierry Hauet; Michel Pinsard; Frederic Favreau
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

6.  Exocyst Sec10 protects epithelial barrier integrity and enhances recovery following oxidative stress, by activation of the MAPK pathway.

Authors:  Kwon Moo Park; Ben Fogelgren; Xiaofeng Zuo; Jinu Kim; Daniel C Chung; Joshua H Lipschutz
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-06

7.  PARP-1 inhibits glycolysis in ischemic kidneys.

Authors:  Kishor Devalaraja-Narashimha; Babu J Padanilam
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

8.  Expression of SDF-1/CXCR4 in injured human kidneys.

Authors:  Danny Lotan; Natalia Sheinberg; Jury Kopolovic; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2007-10-31       Impact factor: 3.714

Review 9.  Renal endothelial dysfunction in acute kidney ischemia reperfusion injury.

Authors:  David P Basile; Mervin C Yoder
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2014

Review 10.  Acute renal failure: definitions, diagnosis, pathogenesis, and therapy.

Authors:  Robert W Schrier; Wei Wang; Brian Poole; Amit Mitra
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.